Logo
x

Search

Subscribe Now

Adaptimmune

Adaptimmune’s Tecelra Gains the US FDA’s Accelerated Approval to Treat Synovial Sarcoma

Adaptimmune’s Tecelra Gains the US FDA’s Accelerated Approval to Treat Synovial Sarcoma

  • August 5, 2024
Adaptimmune Reports Results of Lete-cel in P-II Trial to Treat Synovial Sarcoma and Myxoid/Round Cell Liposarcoma (MRCLS)

Adaptimmune Reports Results of Lete-cel in P-II Trial to Treat Synovial Sarcoma and Myxoid/Round Cell Liposarcoma (MRCLS)

  • November 2, 2023
Adaptimmune Reports P-II (SPEARHEAD-1) Trial Results of Afami-cel for the Treatment of Synovial Sarcoma at CTOS 2022

Adaptimmune Reports P-II (SPEARHEAD-1) Trial Results of Afami-cel for the Treatment of Synovial Sarcoma at CTOS 2022

  • November 21, 2022
PharmaShots Interview: Adaptimmune's Dennis Williams Shares Insight About the Company's Pathway to Bringing the First-Ever TCR T-Cell Therapy for Solid Tumors to Market

PharmaShots Interview: Adaptimmune's Dennis Williams Shares Insight About the Company's Pathway to Bringing the First-Ever TCR T-C...

  • August 16, 2021
Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20

Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20

  • June 1, 2020
PharmaShots Weekly Snapshot (January 13-17, 2020)

PharmaShots Weekly Snapshot (January 13-17, 2020)

  • January 20, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.